TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12593950
log Bayes Factor = 17.8006
Chromosome 15   position 78,920,935  (GRCh37) Explore rs12593950 on Ensembl!
Variant rs12593950 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
J44.9 Chronic obstructive pulmonary disease, unspecified
0.000 0.000 1.000
J44 Other chronic obstructive pulmonary disease
0.000 0.000 1.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.000 0.000 1.000
I70-I79 Diseases of arteries, arterioles and capillaries
0.000 0.000 1.000
J43.9 Emphysema, unspecified
0.000 0.000 1.000
I71 Aortic aneurysm and dissection
0.000 0.000 1.000
J43 Emphysema
0.000 0.001 0.999
I71.4 Abdominal aortic aneurysm, without mention of rupture
0.000 0.001 0.999
J40-J47 Chronic lower respiratory diseases
0.000 0.002 0.998
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.000 0.003 0.997
I73 Other peripheral vascular diseases
0.000 0.005 0.995
I73.9 Peripheral vascular disease, unspecified
0.000 0.009 0.991
I70 Atherosclerosis
0.000 0.016 0.984
I71.9 Aortic aneurysm of unspecified site, without mention of rupture
0.000 0.023 0.977
I70.2 Atherosclerosis of arteries of the extremities
0.000 0.023 0.977
I77 Other disorders of arteries and arterioles
0.000 0.025 0.975
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.000 0.031 0.969
J42 Unspecified chronic bronchitis
0.000 0.065 0.935
I77.1 Stricture of artery
0.000 0.070 0.930
I71.3 Abdominal aortic aneurysm, ruptured
0.000 0.094 0.906
I77.9 Disorder of arteries and arterioles, unspecified
0.000 0.102 0.898
I74 Arterial embolism and thrombosis
0.000 0.103 0.897
I72 Other aneurysm
0.000 0.160 0.840
J43.2 Centrilobular emphysema
0.000 0.174 0.826
I70.21 Atherosclerosis of arteries of extremities (with gangrene)
0.000 0.208 0.792
I73.0 Raynaud's syndrome
0.000 0.209 0.791
I77.0 Arteriovenous fistula, acquired
0.000 0.230 0.770
I77.2 Rupture of artery
0.000 0.231 0.769
I74.3 Embolism and thrombosis of arteries of the lower extremities
0.000 0.234 0.766
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture
0.000 0.238 0.762
I72.8 Aneurysm of other specified arteries
0.000 0.265 0.735
J44.8 Other specified chronic obstructive pulmonary disease
0.000 0.269 0.731
I74.2 Embolism and thrombosis of arteries of the upper extremities
0.000 0.276 0.724
I71.8 Aortic aneurysm of unspecified site, ruptured
0.000 0.283 0.717
I71.5 Thoracoabdominal aortic aneurysm, ruptured
0.000 0.283 0.717
I71.1 Thoracic aortic aneurysm, ruptured
0.000 0.283 0.717
J43.1 Panlobular emphysema
0.000 0.284 0.716
J43.0 MacLeod's syndrome
0.000 0.284 0.716
J41 Simple and mucopurulent chronic bronchitis
0.000 0.285 0.715
I74.5 Embolism and thrombosis of iliac artery
0.000 0.285 0.715
I73.1 Thromboangiitis obliterans [Buerger]
0.000 0.287 0.713
I70.9 Generalised and unspecified atherosclerosis
0.000 0.294 0.706
I70.8 Atherosclerosis of other arteries
0.000 0.294 0.706
I70.0 Atherosclerosis of aorta
0.000 0.295 0.705
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.000 0.295 0.705
I77.5 Necrosis of artery
0.000 0.301 0.699
I77.4 Coeliac artery compression syndrome
0.000 0.301 0.699
I74.8 Embolism and thrombosis of other arteries
0.000 0.328 0.672
I78 Diseases of capillaries
0.000 0.331 0.669
I72.0 Aneurysm of carotid artery
0.000 0.334 0.666
I74.9 Embolism and thrombosis of unspecified artery
0.000 0.344 0.656
I77.8 Other specified disorders of arteries and arterioles
0.000 0.349 0.651
J43.8 Other emphysema
0.000 0.355 0.645
I74.1 Embolism and thrombosis of other and unspecified parts of aorta
0.000 0.357 0.643
I73.8 Other specified peripheral vascular diseases
0.000 0.358 0.642
I72.9 Aneurysm of unspecified site
0.000 0.371 0.629
J40 Bronchitis, not specified as acute or chronic
0.000 0.376 0.624
I74.0 Embolism and thrombosis of abdominal aorta
0.000 0.383 0.617
I71.0 Dissection of aorta [any part]
0.000 0.394 0.606
I72.6 Aneurysm and dissection of vertebral artery
0.000 0.398 0.602
I72.5 Aneurysm and dissection of other precerebral arteries
0.000 0.398 0.602
I72.1 Aneurysm of artery of upper extremity
0.000 0.398 0.602
I74.4 Embolism and thrombosis of arteries of extremities, unspecified
0.000 0.419 0.581
I70.1 Atherosclerosis of renal artery
0.000 0.420 0.580
I77.3 Arterial fibromuscular dysplasia
0.000 0.422 0.578
I72.4 Aneurysm of artery of lower extremity
0.000 0.424 0.576
I72.3 Aneurysm of iliac artery
0.000 0.428 0.572
I78.0 Hereditary haemorrhagic telangiectasia
0.000 0.458 0.542
I77.6 Arteritis, unspecified
0.000 0.462 0.538
J46 Status asthmaticus
0.000 0.470 0.530
I79.2 Peripheral angiopathy in diseases classified elsewhere
0.000 0.470 0.530
I72.2 Aneurysm of renal artery
0.000 0.477 0.523
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.000 0.487 0.513
J41.1 Mucopurulent chronic bronchitis
0.000 0.487 0.513
J41.0 Simple chronic bronchitis
0.000 0.487 0.513
I70.81 Atherosclerosis of other arteries (with gangrene)
0.000 0.494 0.506
I70.80 Atherosclerosis of other arteries (without gangrene)
0.000 0.494 0.506
I70.91 Generalized and unspecified atherosclerosis (with gangrene)
0.000 0.494 0.506
I70.90 Generalized and unspecified atherosclerosis (without gangrene)
0.000 0.494 0.506
I70.01 Atherosclerosis of aorta (with gangrene)
0.000 0.494 0.506
I79.1 Aortitis in diseases classified elsewhere
0.000 0.494 0.506
I79.0 Aneurysm of aorta in diseases classified elsewhere
0.000 0.494 0.506
I70.00 Atherosclerosis of aorta (without gangrene)
0.000 0.495 0.505
I78.9 Disease of capillaries, unspecified
0.000 0.520 0.480
I78.8 Other diseases of capillaries
0.000 0.531 0.469
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.000 0.535 0.465
I70.11 Atherosclerosis of renal artery (with gangrene)
0.000 0.584 0.416
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.000 0.602 0.397
I78.1 Naevus, nonneoplastic
0.000 0.668 0.332
I70.10 Atherosclerosis of renal artery (without gangrene)
0.001 0.709 0.290
J45 Asthma
0.000 0.823 0.177
E11.3 With ophthalmic complications
0.000 0.853 0.147
E11 Non-insulin-dependent diabetes mellitus
0.000 0.854 0.146
E11.2 With renal complications
0.000 0.861 0.139
E11.5 With peripheral circulatory complications
0.000 0.864 0.136
E11.4 With neurological complications
0.000 0.871 0.129
J45.8 Mixed asthma
0.000 0.873 0.127
E11.0 With coma
0.000 0.877 0.123
J45.1 Nonallergic asthma
0.000 0.881 0.118
E11.8 With unspecified complications
0.000 0.882 0.118
Chapter X Diseases of the respiratory system
0.000 0.883 0.117
J47 Bronchiectasis
0.000 0.886 0.114
J90-J94 Other diseases of pleura
0.000 0.890 0.110
J92 Pleural plaque
0.000 0.893 0.107
E11.7 With multiple complications
0.000 0.895 0.105
J60-J70 Lung diseases due to external agents
0.000 0.896 0.104
J93 Pneumothorax
0.000 0.897 0.103
J92.9 Pleural plaque without asbestos
0.000 0.898 0.102
E11.1 With ketoacidosis
0.000 0.899 0.101
E11.6 With other specified complications
0.000 0.901 0.099
J93.1 Other spontaneous pneumothorax
0.000 0.902 0.098
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.000 0.902 0.098
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.000 0.905 0.095
J92.0 Pleural plaque with presence of asbestos
0.000 0.909 0.091
J95-J99 Other diseases of the respiratory system
0.000 0.911 0.089
J86 Pyothorax
0.000 0.913 0.087
J60 Coalworker's pneumoconiosis
0.000 0.917 0.083
J93.9 Pneumothorax, unspecified
0.000 0.918 0.082
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.082 0.918 0.000
J86.9 Pyothorax without fistula
0.000 0.920 0.080
J64 Unspecified pneumoconiosis
0.000 0.924 0.076
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
0.000 0.925 0.075
J66 Airway disease due to specific organic dust
0.000 0.925 0.075
J63 Pneumoconiosis due to other inorganic dusts
0.000 0.925 0.075
J62 Pneumoconiosis due to dust containing silica
0.000 0.925 0.075
J65 Pneumoconiosis associated with tuberculosis
0.000 0.925 0.075
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.073 0.927 0.000
J93.0 Spontaneous tension pneumothorax
0.000 0.928 0.072
J70 Respiratory conditions due to other external agents
0.000 0.928 0.071
J69 Pneumonitis due to solids and liquids
0.000 0.929 0.071
J67 Hypersensitivity pneumonitis due to organic dust
0.000 0.929 0.071
J95 Postprocedural respiratory disorders, not elsewhere classified
0.000 0.931 0.069
J93.8 Other pneumothorax
0.000 0.933 0.067
J99 Respiratory disorders in diseases classified elsewhere
0.000 0.934 0.066
J96 Respiratory failure, not elsewhere classified
0.000 0.936 0.064
J86.0 Pyothorax with fistula
0.000 0.936 0.064
J98 Other respiratory disorders
0.000 0.938 0.062
J85 Abscess of lung and mediastinum
0.000 0.938 0.061
J91 Pleural effusion in conditions classified elsewhere
0.000 0.939 0.061
T43.2 Other and unspecified antidepressants
0.061 0.939 0.000
J95.8 Other postprocedural respiratory disorders
0.000 0.939 0.061
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.060 0.940 0.000
J94 Other pleural conditions
0.000 0.940 0.060
E10-E14 Diabetes mellitus
0.000 0.940 0.060
N64 Other disorders of breast
0.059 0.941 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.059 0.941 0.000
T42.0 Hydantoin derivatives
0.058 0.942 0.000
N64.5 Other signs and symptoms in breast
0.058 0.942 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.058 0.942 0.000
N64.8 Other specified disorders of breast
0.058 0.942 0.000
J69.8 Pneumonitis due to other solids and liquids
0.000 0.944 0.056
E13 Other specified diabetes mellitus
0.000 0.944 0.056
J99.1 Respiratory disorders in other diffuse connective tissue disorders
0.000 0.945 0.055
T42.4 Benzodiazepines
0.055 0.945 0.000
J98.9 Respiratory disorder, unspecified
0.000 0.946 0.054
J62.8 Pneumoconiosis due to other dust containing silica
0.000 0.946 0.054
J62.0 Pneumoconiosis due to talc dust
0.000 0.946 0.054
J63.8 Pneumoconiosis due to other specified inorganic dusts
0.000 0.946 0.054
J63.5 Stannosis
0.000 0.946 0.054
J63.4 Siderosis
0.000 0.946 0.054
J63.3 Graphite fibrosis (of lung)
0.000 0.946 0.054
J63.2 Berylliosis
0.000 0.946 0.054
J63.1 Bauxite fibrosis (of lung)
0.000 0.946 0.054
J63.0 Aluminosis (of lung)
0.000 0.946 0.054
J66.8 Airway disease due to other specific organic dusts
0.000 0.946 0.054
J66.2 Cannabinosis
0.000 0.946 0.054
J66.1 Flax-dresser's disease
0.000 0.946 0.054
J66.0 Byssinosis
0.000 0.946 0.054
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours
0.000 0.946 0.054
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours
0.000 0.946 0.054
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours
0.000 0.946 0.054
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours
0.000 0.946 0.054
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified
0.000 0.946 0.054
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours
0.000 0.946 0.054
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours
0.000 0.946 0.054
E13.9 Without complications
0.000 0.946 0.054
T46 Poisoning by agents primarily affecting the cardiovascular system
0.053 0.947 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.052 0.948 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.052 0.948 0.000
T42.3 Barbiturates
0.052 0.948 0.000
T42.2 Succinimides and oxazolidinediones
0.052 0.948 0.000
N64.9 Disorder of breast, unspecified
0.052 0.948 0.000
J70.9 Respiratory conditions due to unspecified external agent
0.000 0.948 0.051
J70.8 Respiratory conditions due to other specified external agents
0.000 0.948 0.051
J70.4 Drug-induced interstitial lung disorder, unspecified
0.000 0.948 0.051
J70.3 Chronic drug-induced interstitial lung disorders
0.000 0.948 0.051
J70.2 Acute drug-induced interstitial lung disorders
0.000 0.948 0.051
J70.0 Acute pulmonary manifestations due to radiation
0.000 0.948 0.051
J69.1 Pneumonitis due to oils and essences
0.000 0.949 0.051
N64.4 Mastodynia
0.051 0.949 0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts
0.000 0.949 0.051
J67.7 Air-conditioner and humidifier lung
0.000 0.949 0.051
J67.6 Maple-bark-stripper's lung
0.000 0.949 0.051
J67.5 Mushroom-worker's lung
0.000 0.949 0.051
J67.4 Maltworker's lung
0.000 0.949 0.051
J67.3 Suberosis
0.000 0.949 0.051
J67.1 Bagassosis
0.000 0.949 0.051
J67.0 Farmer's lung
0.000 0.949 0.051
N64.1 Fat necrosis of breast
0.051 0.949 0.000
T42.1 Iminostilbenes
0.051 0.949 0.000
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust
0.000 0.949 0.051
J98.1 Pulmonary collapse
0.000 0.950 0.050
T43.5 Other and unspecified antipsychotics and neuroleptics
0.050 0.950 0.000
J95.5 Postprocedural subglottic stenosis
0.000 0.950 0.050
J95.4 Mendelson's syndrome
0.000 0.950 0.050
J95.3 Chronic pulmonary insufficiency following surgery
0.000 0.950 0.050
J95.2 Acute pulmonary insufficiency following nonthoracic surgery
0.000 0.950 0.050
J95.1 Acute pulmonary insufficiency following thoracic surgery
0.000 0.950 0.050
T43.0 Tricyclic and tetracyclic antidepressants
0.049 0.951 0.000
J00-J06 Acute upper respiratory infections
0.000 0.951 0.049
J70.1 Chronic and other pulmonary manifestations due to radiation
0.000 0.952 0.048
J98.4 Other disorders of lung
0.000 0.952 0.048
J99.0 Rheumatoid lung disease
0.000 0.952 0.048
J67.2 Bird fancier's lung
0.000 0.952 0.048
J98.2 Interstitial emphysema
0.000 0.952 0.048
J80-J84 Other respiratory diseases principally affecting the interstitium
0.001 0.953 0.047
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.047 0.953 0.000
J85.1 Abscess of lung with pneumonia
0.000 0.953 0.047
J96.9 Respiratory failure, unspecified
0.000 0.954 0.046
J96.1 Chronic respiratory failure
0.000 0.954 0.046
J96.0 Acute respiratory failure
0.000 0.954 0.046
J95.9 Postprocedural respiratory disorder, unspecified
0.000 0.954 0.045
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.045 0.955 0.000
J98.3 Compensatory emphysema
0.000 0.955 0.045
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.044 0.955 0.000
J85.3 Abscess of mediastinum
0.000 0.956 0.044
J85.0 Gangrene and necrosis of lung
0.000 0.956 0.044
J84 Other interstitial pulmonary diseases
0.000 0.956 0.044
T46.5 Other antihypertensive drugs, not elsewhere classified
0.044 0.956 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.044 0.956 0.000
J95.0 Tracheostomy malfunction
0.000 0.956 0.044
J94.1 Fibrothorax
0.000 0.956 0.044
J90 Pleural effusion, not elsewhere classified
0.000 0.957 0.043
T43.9 Psychotropic drug, unspecified
0.043 0.957 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.043 0.957 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.043 0.957 0.000
J94.9 Pleural condition, unspecified
0.000 0.957 0.043
J94.0 Chylous effusion
0.000 0.957 0.043
E12 Malnutrition-related diabetes mellitus
0.000 0.957 0.043
N64.3 Galactorrhoea not associated with childbirth
0.043 0.957 0.000
N64.2 Atrophy of breast
0.043 0.957 0.000
N64.0 Fissure and fistula of nipple
0.043 0.957 0.000
J94.8 Other specified pleural conditions
0.000 0.957 0.042
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.042 0.958 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.042 0.958 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.042 0.958 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.042 0.958 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.042 0.958 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.042 0.958 0.000
J20-J22 Other acute lower respiratory infections
0.000 0.958 0.042
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.042 0.958 0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis
0.000 0.959 0.041
J69.0 Pneumonitis due to food and vomit
0.000 0.959 0.041
J84.9 Interstitial pulmonary disease, unspecified
0.000 0.959 0.041
T46.4 Angiotensin-converting-enzyme inhibitors
0.040 0.960 0.000
E13.8 With unspecified complications
0.000 0.960 0.040
E13.7 With multiple complications
0.000 0.960 0.040
E13.6 With other specified complications
0.000 0.960 0.040
E13.5 With peripheral circulatory complications
0.000 0.960 0.040
E13.4 With neurological complications
0.000 0.960 0.040
E13.3 With ophthalmic complications
0.000 0.960 0.040
E13.2 With renal complications
0.000 0.960 0.040
E13.1 With ketoacidosis
0.000 0.960 0.040
E13.0 With coma
0.000 0.960 0.040
J98.0 Diseases of bronchus, not elsewhere classified
0.000 0.960 0.040
J00 Acute nasopharyngitis [common cold]
0.000 0.960 0.040
T43.4 Butyrophenone and thioxanthene neuroleptics
0.039 0.961 0.000
J98.8 Other specified respiratory disorders
0.000 0.961 0.039
T36 Poisoning by systemic antibiotics
0.039 0.961 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.038 0.962 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.038 0.962 0.000
T46.7 Peripheral vasodilators
0.038 0.962 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.038 0.962 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.038 0.962 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.037 0.963 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.036 0.964 0.000
T43.6 Psychostimulants with abuse potential
0.036 0.964 0.000
J99.8 Respiratory disorders in other diseases classified elsewhere
0.000 0.964 0.036
T38.1 Thyroid hormones and substitutes
0.036 0.964 0.000
J84.1 Other interstitial pulmonary diseases with fibrosis
0.000 0.964 0.036
J05.1 Acute epiglottitis
0.000 0.965 0.035
J45.0 Predominantly allergic asthma
0.000 0.965 0.035
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.035 0.965 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.035 0.965 0.000
T45.0 Antiallergic and antiemetic drugs
0.035 0.965 0.000
E14 Unspecified diabetes mellitus
0.000 0.965 0.035
T47.0 Histamine H(2)-receptor antagonists
0.034 0.966 0.000
T38.9 Other and unspecified hormone antagonists
0.034 0.966 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.034 0.966 0.000
T38.7 Androgens and anabolic congeners
0.034 0.966 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.034 0.966 0.000
T38.5 Other oestrogens and progestogens
0.034 0.966 0.000
T38.4 Oral contraceptives
0.034 0.966 0.000
T38.2 Antithyroid drugs
0.034 0.966 0.000
T38.0 Glucocorticoids and synthetic analogues
0.034 0.966 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.034 0.966 0.000
J96.09 Acute respiratory failure; Type unspecified
0.000 0.967 0.033
J96.01 Acute respiratory failure; Type II [hypercapnic]
0.000 0.967 0.033
J96.00 Acute respiratory failure; Type I [hypoxic]
0.000 0.967 0.033
J96.19 Chronic respiratory failure; Type unspecified
0.000 0.967 0.033
J96.11 Chronic respiratory failure; Type II [hypercapnic]
0.000 0.967 0.033
J96.10 Chronic respiratory failure; Type I [hypoxic]
0.000 0.967 0.033
J96.99 Respiratory failure, unspecified; Type unspecified
0.000 0.967 0.033
J96.91 Respiratory failure unspecified; Type II [hypercapnic]
0.000 0.967 0.033
J96.90 Respiratory failure, unspecified; Type I [hypoxic]
0.000 0.967 0.033
J84.8 Other specified interstitial pulmonary diseases
0.000 0.967 0.033
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.033 0.967 0.000
J98.6 Disorders of diaphragm
0.000 0.967 0.033
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.032 0.968 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.032 0.968 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.032 0.968 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.032 0.968 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.032 0.968 0.000
T44.0 Anticholinesterase agents
0.032 0.968 0.000
J04 Acute laryngitis and tracheitis
0.000 0.968 0.032
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.032 0.968 0.000
J84.0 Alveolar and parietoalveolar conditions
0.000 0.968 0.032
T45.9 Primarily systemic and haematological agent, unspecified
0.032 0.968 0.000
T45.8 Other primarily systemic and haematological agents
0.032 0.968 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.032 0.968 0.000
T45.6 Fibrinolysis-affecting drugs
0.032 0.968 0.000
T45.4 Iron and its compounds
0.032 0.968 0.000
T45.3 Enzymes, not elsewhere classified
0.032 0.968 0.000
J85.2 Abscess of lung without pneumonia
0.001 0.969 0.031
E12.9 Without complications
0.000 0.969 0.031
E12.8 With unspecified complications
0.000 0.969 0.031
E12.7 With multiple complications
0.000 0.969 0.031
E12.6 With other specified complications
0.000 0.969 0.031
E12.5 With peripheral circulatory complications
0.000 0.969 0.031
E12.4 With neurological complications
0.000 0.969 0.031
E12.3 With ophthalmic complications
0.000 0.969 0.031
E12.2 With renal complications
0.000 0.969 0.031
E12.1 With ketoacidosis
0.000 0.969 0.031
E12.0 With coma
0.000 0.969 0.031
T45.2 Vitamins, not elsewhere classified
0.031 0.969 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.030 0.969 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.030 0.969 0.000
T37.5 Antiviral drugs
0.030 0.969 0.000
T37.4 Anthelminthics
0.030 0.969 0.000
T37.3 Other antiprotozoal drugs
0.030 0.969 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.030 0.969 0.000
T37.1 Antimycobacterial drugs
0.030 0.969 0.000
T37.0 Sulphonamides
0.030 0.969 0.000
T41.5 Therapeutic gases
0.030 0.969 0.000
T41.4 Anaesthetic, unspecified
0.030 0.969 0.000
T41.3 Local anaesthetics
0.030 0.969 0.000
T41.2 Other and unspecified general anaesthetics
0.030 0.969 0.000
T41.1 Intravenous anaesthetics
0.030 0.969 0.000
T41.0 Inhaled anaesthetics
0.030 0.969 0.000
T49.9 Topical agent, unspecified
0.030 0.969 0.000
T49.8 Other topical agents
0.030 0.969 0.000
T49.7 Dental drugs, topically applied
0.030 0.969 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.030 0.969 0.000
T49.5 Ophthalmological drugs and preparations
0.030 0.969 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.030 0.969 0.000
T49.3 Emollients, demulcents and protectants
0.030 0.969 0.000
T49.2 Local astringents and local detergents
0.030 0.969 0.000
T49.1 Antipruritics
0.030 0.969 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.030 0.969 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.030 0.969 0.000
T48.5 Anti-common-cold drugs
0.030 0.969 0.000
T48.4 Expectorants
0.030 0.969 0.000
T48.3 Antitussives
0.030 0.969 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.030 0.969 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.030 0.969 0.000
T48.0 Oxytocic drugs
0.030 0.969 0.000
M50.2 Other cervical disk displacement
0.000 0.970 0.030
E14.3 With ophthalmic complications
0.000 0.970 0.030
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.030 0.970 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.030 0.970 0.000
T47.7 Emetics
0.030 0.970 0.000
T47.6 Antidiarrhoeal drugs
0.030 0.970 0.000
T47.5 Digestants
0.030 0.970 0.000
T47.4 Other laxatives
0.030 0.970 0.000
T47.3 Saline and osmotic laxatives
0.030 0.970 0.000
T47.2 Stimulant laxatives
0.030 0.970 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.030 0.970 0.000
J01 Acute sinusitis
0.000 0.970 0.030
T40.4 Other synthetic narcotics
0.030 0.970 0.000
J20 Acute bronchitis
0.000 0.970 0.030
J05.0 Acute obstructive laryngitis [croup]
0.000 0.970 0.030
M50.0 Cervical disk disorder with myelopathy
0.000 0.971 0.029
C67.2 Lateral wall of bladder
0.000 0.972 0.028
T36.9 Systemic antibiotic, unspecified
0.028 0.972 0.000
T36.8 Other systemic antibiotics
0.028 0.972 0.000
T36.7 Antifungal antibiotics, systemically used
0.028 0.972 0.000
T36.6 Rifamycins
0.028 0.972 0.000
T36.5 Aminoglycosides
0.028 0.972 0.000
T36.4 Tetracyclines
0.028 0.972 0.000
T36.3 Macrolides
0.028 0.972 0.000
T36.2 Chloramphenicol group
0.028 0.972 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.028 0.972 0.000
M50 Cervical disk disorders
0.000 0.972 0.028
C67 Malignant neoplasm of bladder
0.000 0.972 0.028
T45.5 Anticoagulants
0.028 0.972 0.000
T46.1 Calcium-channel blockers
0.028 0.972 0.000
J98.5 Diseases of mediastinum, not elsewhere classified
0.000 0.972 0.027
C67.6 Ureteric orifice
0.000 0.973 0.027
C67.3 Anterior wall of bladder
0.000 0.973 0.027
J03 Acute tonsillitis
0.000 0.974 0.026
E14.8 With unspecified complications
0.000 0.974 0.026
T40.6 Other and unspecified narcotics
0.026 0.974 0.000
J21 Acute bronchiolitis
0.000 0.974 0.026
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.026 0.974 0.000
T40.8 Lysergide [LSD]
0.026 0.974 0.000
T40.7 Cannabis (derivatives)
0.026 0.974 0.000
T40.5 Cocaine
0.026 0.974 0.000
T40.3 Methadone
0.026 0.974 0.000
T40.1 Heroin
0.026 0.974 0.000
T40.0 Opium
0.026 0.974 0.000
E14.4 With neurological complications
0.000 0.974 0.026
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.026 0.974 0.000
E14.7 With multiple complications
0.000 0.975 0.025
E14.0 With coma
0.000 0.975 0.025
E14.1 With ketoacidosis
0.000 0.975 0.025
C67.1 Dome of bladder
0.000 0.975 0.025
T36.0 Penicillins
0.024 0.975 0.000
J02 Acute pharyngitis
0.000 0.976 0.024
M50.1 Cervical disk disorder with radiculopathy
0.000 0.976 0.024
J04.1 Acute tracheitis
0.000 0.976 0.024
J94.2 Haemothorax
0.001 0.976 0.023
T50.8 Diagnostic agents
0.023 0.977 0.000
J04.2 Acute laryngotracheitis
0.000 0.977 0.023
T50.7 Analeptics and opioid receptor antagonists
0.023 0.977 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.023 0.977 0.000
T50.5 Appetite depressants
0.023 0.977 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.023 0.977 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.023 0.977 0.000
T50.1 Loop [high-ceiling] diuretics
0.023 0.977 0.000
T50.0 Mineralocorticoids and their antagonists
0.023 0.977 0.000
J06 Acute upper respiratory infections of multiple and unspecified sites
0.000 0.977 0.023
T47.1 Other antacids and anti-gastric-secretion drugs
0.023 0.977 0.000
M50.9 Cervical disk disorder, unspecified
0.000 0.977 0.023
E14.5 With peripheral circulatory complications
0.000 0.977 0.022
T50.4 Drugs affecting uric acid metabolism
0.022 0.977 0.000
J20.8 Acute bronchitis due to other specified organisms
0.000 0.977 0.022
E14.6 With other specified complications
0.000 0.978 0.022
J82 Pulmonary eosinophilia, not elsewhere classified
0.001 0.978 0.021
C67.5 Bladder neck
0.000 0.978 0.022
J01.8 Other acute sinusitis
0.000 0.978 0.022
J01.4 Acute pansinusitis
0.000 0.978 0.022
J01.3 Acute sphenoidal sinusitis
0.000 0.978 0.022
J01.1 Acute frontal sinusitis
0.000 0.978 0.022
C34.1 Upper lobe, bronchus or lung
0.000 0.978 0.022
J20.7 Acute bronchitis due to echovirus
0.000 0.978 0.021
J20.6 Acute bronchitis due to rhinovirus
0.000 0.978 0.021
J20.5 Acute bronchitis due to respiratory syncytial virus
0.000 0.978 0.021
J20.4 Acute bronchitis due to parainfluenza virus
0.000 0.978 0.021
J20.3 Acute bronchitis due to coxsackie virus
0.000 0.978 0.021
J20.2 Acute bronchitis due to streptococcus
0.000 0.978 0.021
J20.1 Acute bronchitis due to Haemophilus influenzae
0.000 0.978 0.021
J20.0 Acute bronchitis due to Mycoplasma pneumoniae
0.000 0.978 0.021
J01.0 Acute maxillary sinusitis
0.000 0.979 0.021
E21.0 Primary hyperparathyroidism
0.000 0.979 0.021
F17.1 Harmful use
0.000 0.979 0.021
M50.8 Other cervical disk disorders
0.000 0.979 0.020
C67.7 Urachus
0.000 0.980 0.020
J01.9 Acute sinusitis, unspecified
0.000 0.980 0.020
C67.8 Overlapping lesion of bladder
0.000 0.980 0.020
E14.2 Withrenal complications
0.000 0.980 0.020
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.980 0.020
J20.9 Acute bronchitis, unspecified
0.000 0.980 0.020
J04.0 Acute laryngitis
0.000 0.981 0.019
J03.8 Acute tonsillitis due to other specified organisms
0.000 0.981 0.019
J03.0 Streptococcal tonsillitis
0.000 0.981 0.019
J21.8 Acute bronchiolitis due to other specified organisms
0.000 0.981 0.019
J21.1 Acute bronchiolitis due to human metapneumovirus
0.000 0.981 0.019
J21.0 Acute bronchiolitis due to respiratory syncytial virus
0.000 0.981 0.019
E21.3 Hyperparathyroidism, unspecified
0.000 0.981 0.019
J01.2 Acute ethmoidal sinusitis
0.000 0.981 0.019
C67.4 Posterior wall of bladder
0.000 0.982 0.018
J02.8 Acute pharyngitis due to other specified organisms
0.000 0.982 0.018
J06.8 Other acute upper respiratory infections of multiple sites
0.000 0.983 0.017
J06.0 Acute laryngopharyngitis
0.000 0.983 0.017
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.983 0.016
C34 Malignant neoplasm of bronchus and lung
0.000 0.984 0.016
E14.9 Without complications
0.000 0.984 0.016
C67.0 Trigone of bladder
0.000 0.984 0.016
J09-J18 Influenza and pneumonia
0.000 0.984 0.016
C34.9 Bronchus or lung, unspecified
0.000 0.984 0.016
J02.0 Streptococcal pharyngitis
0.000 0.984 0.015
Y95 Nosocomial condition
0.000 0.985 0.015
J21.9 Acute bronchiolitis, unspecified
0.000 0.985 0.015
F17 Mental and behavioural disorders due to use of tobacco
0.000 0.985 0.015
E21.4 Other specified disorders of parathyroid gland
0.000 0.985 0.014
E21.2 Other hyperparathyroidism
0.000 0.985 0.014
F17.2 Dependence syndrome
0.000 0.986 0.014
M50.3 Other cervical disk degeneration
0.000 0.986 0.014
C64-C68 Malignant neoplasms of urinary tract
0.000 0.986 0.014
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.986 0.014
C34.3 Lower lobe, bronchus or lung
0.000 0.987 0.013
T50.9 Other and unspecified drugs, medicaments and biological substances
0.013 0.987 0.000
E20-E35 Disorders of other endocrine glands
0.000 0.987 0.013
C34.2 Middle lobe, bronchus or lung
0.000 0.988 0.012
C65 Malignant neoplasm of renal pelvis
0.000 0.988 0.012
J10 Influenza due to identified influenza virus
0.000 0.988 0.012
J16 Pneumonia due to other infectious organisms, not elsewhere classified
0.000 0.988 0.012
J09 Influenza due to certain identified influenza virus
0.000 0.988 0.012
K70.9 Alcoholic liver disease, unspecified
0.000 0.989 0.011
J17 Pneumonia in diseases classified elsewhere
0.000 0.989 0.011

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.